The full submission can be read here Submission to: Finance and Expenditure CommitteeSubject: Budget Policy Statement 2024From: New Zealanders for Health Research (NZHR)1Date: 22nd April 2024RecommendationsNew Zealanders for Health Research (NZHR) recommends that BPS 2024:

Following our written submission to Parliament’s Health Committee we have followed up with an oral submission where we’ve referenced submissions from NZHR members Douglas Pharmaceuticals, Malaghan Institute and MSD (Merck) in order to amplify both their voices and our own. The text of the oral submission can be read here

NZHR has made a submission on the Therapeutic Products Bill. Because products used in clinical trials are yet to be confirmed or otherwise as being therapeutic they need to be unambiguously exempted from many of the Bill’s provisions. It is also important that the new legislation does not impose additional burdens on the carrying out…

NZHR has made a submission to Parliament’s Finance and Expenditure Committee recommending that the 2023 Budget Policy Statement The full submission can be read here

Click here to read the latest newsletter

On 29th November 2022 at NZHR’s “health research at crossroads” workshop Dr Ian Town, Chief Science Advisor, Ministry of Health, presented on the place and role of health research and clinical trials in New Zealand’s reformed health sector. His presentation can be viewed here

On 29th November 2022 at NZHR’s “health research at crossroads” workshop Sarah Hogan, Principal Economist, New Zealand Institute of Economic Research (NZIER), presented findings from and NZHR commissioned report into the economic value of investing in health research. Her presentation can be viewed here

NZHR’s 2022 annual report which outlines our advocacy and other activities for the year ending June 2022 can be read here